Pursuing a Brighter Future by Clearing Human Diseases

Advancing multi-specific platforms inspired by the natural precision of the human immune system.

Our Vision

NextGenVax is dedicated to developing groundbreaking immunotherapies. By leveraging precision medicine, we bridge the gap between discovery and cure, empowering the patient's own immune system to target and erase tumors and infectious diseases directly.

Innovation Support

-

NextGenVax is advancing a differentiated vaccine platform designed to address key limitations of conventional injectable approaches. Our innovation focus centers on scalable mucosal delivery, simplified administration, and modular platform design that can be adapted across infectious disease and cancer applications. This approach supports faster development, broader accessibility, and stronger readiness for future clinical and commercial translation.

Our Technology

-

Our technology combines a modular antigen design with targeted immune activation in a nasal delivery format. It is built to enhance mucosal and systemic immunity while reducing the burden associated with traditional needle-based administration.

The platform integrates immune-enhancing components, disease-relevant targets, and guidance elements within a nanoparticle-based framework to improve uptake, response, and development flexibility across multiple indications.

Leadership

-

Our world-class advisory board comprises leaders in immunology, oncology, and biotechnology. Together, we bridge the gap between complex molecular research and life-saving clinical applications, ensuring NextGenVax remains at the pinnacle of vaccine innovation.

Operational Hub

Oslo Biotech Incubator

Located in the heart of Oslo's thriving life sciences district, our headquarters serves as a hub for international collaboration and cutting-edge laboratory research.